Dr Mike Jones – Managing Director – Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
Copyright 2023 – Finance News Network
Source: Finance News Network
19 Nov 2019 - Redcape Hotel Group Limited (ASX:RDC) CEO, Dan Brady discusses FY19 results, company strategy and creating pub venues that become the hub of local communities.
Read More05 Oct 2022 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon discusses recent agreements with Samsung and Nokia and the outlook for the months ahead.
Read More07 Jun 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's phase 1 trial results for its chlorotoxin CAR T (CLTX CAR T) cell therapy targeting glioblastoma.
Read More12 May 2021 - Galan Lithium (ASX:GLN) Managing Director Juan Pablo Vargas de la Vega provides an update on they company's key Hombre Muerto lithium brine project in the Catamarca province of Argentina.
Read More11 Sep 2024 - Linius Technologies Limited (ASX:LNU) CEO James Brennan discusses the company's recent capital raise, partnerships with Prime Focus, Magnify and Avid, and the launch of Captivate, a platform that enables broadcasters to offer personalised video content and compete with social media giants like TikTok and YouTube.
Read More18 Jul 2023 - Dr Shane Oliver, Chief Economist at AMP, discusses the impact of interest rates and alternatives for fighting inflation.
Read More22 Feb 2021 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole talks about the company's strong 1H21 results on the back of increased trading activity, wealth management and continued growth in advisors.
Read More19 Jun 2024 - Patrick Bell, CEO and Director of Finexia Financial Group (ASX:FNX) speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). Topics discussed include the company's Childcare Income Fund and its lending business.
Read More19 Aug 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company's IMP761 drug, which is potentially active in more than 90% of autoimmune diseases.
Read More01 Mar 2021 - Nutritional Growth Solutions Limited (ASX:NGS) Chairman Brian Leedman talks about the science behind the company's nutritional supplement formulae for children, which are designed to promote height and weight.
Read More
